# Inflammatory bowel disease and extracellular matrix: when victim becomes double agent

**Authors:** Roberta Sferra, Antonella Vetuschi, Giovanni Latella, Alfredo Cappariello, Simona Pompili

PMC · DOI: 10.1007/s00011-026-02195-9 · Inflammation Research · 2026-03-17

## TL;DR

This review explores how the extracellular matrix plays a key role in inflammatory bowel disease and intestinal fibrosis.

## Contribution

The paper highlights the ECM's dual role in both sustaining and exacerbating intestinal inflammation.

## Key findings

- ECM is crucial for mucosal healing and maintaining gut structure.
- ECM components interact with immune signals to overactivate the immune system in IBD.
- Few studies have focused on the ECM's role in immune reaction dynamics in IBD.

## Abstract

The extracellular matrix (ECM) represents an intricate network of proteins present in all organs, with specific physical and biochemical functions. ECM is composed of two distinct but connected entities: the basement membrane, located beneath the epithelium, and the interstitial matrix, present in the mucosa and submucosa. Physiologically, ECM modulates several functions, including epithelium turnover, intercellular communications, cell adhesion, differentiation, proliferation, apoptosis, and tissue remodeling.

After an injury, the epithelial barrier fails, affecting the ECM structure and functions. The normal gut structure and functions depend on ECM, which is regulated by ECM-producing cells/ECM-degrading enzymes. Intestinal injury can lead to epithelial barrier disruption and then to acute mucosal inflammation that can heal or become chronic. The ECM is directly involved in mucosal healing, while the key mechanisms leading to the chronicity of intestinal inflammation are unknown. Inflammatory cells release countless cytokines, chemokines, and growth factors, which, by interacting with specific components of the ECM, induce an overactivation of the immune system. In this context, ECM represents an important player in inflammatory diseases, including the inflammatory bowel diseases (IBD) and related complications such as intestinal fibrosis. In the last years, progressive advancements in the knowledge of IBD pathogenesis have provided crucial information for the discovery of new treatments. Nevertheless, few studies investigate the ECM’s multiple roles in the sustenance and the exacerbation of the immune reaction.

This review aims to emphasize the dynamic aspects of the ECM, giving an overview of its direct involvement in intestinal inflammatory diseases and the related intestinal fibrosis.

## Full-text entities

- **Genes:** MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, Mep1a (meprin 1 alpha) [NCBI Gene 17287] {aka Mep-1, Mep-1a, Mep1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, ITGA2B (integrin subunit alpha 2b) [NCBI Gene 3674] {aka BDPLT16, BDPLT2, CD41, CD41B, FMAIT2, GP2B}, MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314] {aka CHDS6, MMP-3, SL-1, STMY, STMY1, STR1}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, EBP (EBP cholestenol delta-isomerase) [NCBI Gene 10682] {aka CDPX2, CHO2, CPX, CPXD, D8D7I, MEND}, MMP14 (matrix metallopeptidase 14) [NCBI Gene 4323] {aka MMP-14, MMP-X1, MT-MMP, MT-MMP 1, MT1-MMP, MT1MMP}, HAS3 (hyaluronan synthase 3) [NCBI Gene 3038], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, ADAM17 (ADAM metallopeptidase domain 17) [NCBI Gene 6868] {aka ADAM18, CD156B, CSVP, HYPT16, NISBD, NISBD1}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, SLAMF1 (signaling lymphocytic activation molecule family member 1) [NCBI Gene 6504] {aka CD150, CDw150, IPO3, SLAM}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TNFRSF1B (TNF receptor superfamily member 1B) [NCBI Gene 7133] {aka CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, TIMP3 (TIMP metallopeptidase inhibitor 3) [NCBI Gene 7078] {aka HSMRK222, K222, K222TA2, SFD}, SMAD7 (SMAD family member 7) [NCBI Gene 4092] {aka CRCS3, MADH7, MADH8}, PLAU (plasminogen activator, urokinase) [NCBI Gene 5328] {aka ATF, BDPLT5, QPD, UPA, URK, u-PA}, FAP (fibroblast activation protein alpha) [NCBI Gene 2191] {aka DPPIV, FAPA, FAPalpha, SIMP}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, MMP10 (matrix metallopeptidase 10) [NCBI Gene 4319] {aka SL-2, STMY2}, AP1S2 (adaptor related protein complex 1 subunit sigma 2) [NCBI Gene 8905] {aka DC22, MRX59, MRXS21, MRXS5, MRXSF, PGS}, BCL2A1 (BCL2 related protein A1) [NCBI Gene 597] {aka ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1}, MADCAM1 (mucosal vascular addressin cell adhesion molecule 1) [NCBI Gene 8174] {aka MACAM1}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, MMP7 (matrix metallopeptidase 7) [NCBI Gene 4316] {aka MMP-7, MPSL1, PUMP-1}, HPSE (heparanase) [NCBI Gene 10855] {aka HPA, HPA1, HPR1, HPSE1, HSE1}, IL22 (interleukin 22) [NCBI Gene 50616] {aka IL-21, IL-22, IL-D110, IL-TIF, ILTIF, TIFIL-23}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, THBS1 (thrombospondin 1) [NCBI Gene 7057] {aka THBS, THBS-1, TSP, TSP-1, TSP1}, TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046] {aka AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1}, LUM (lumican) [NCBI Gene 4060] {aka LDC, SLRR2D}, TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, BMP7 (bone morphogenetic protein 7) [NCBI Gene 655] {aka OP-1}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, IL1RL1 (interleukin 1 receptor like 1) [NCBI Gene 9173] {aka DER4, FIT-1, IL33R, ST2, ST2L, ST2V}, MMP13 (matrix metallopeptidase 13) [NCBI Gene 4322] {aka CLG3, MANDP1, MDST, MMP-13}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, MEP1B (meprin A subunit beta) [NCBI Gene 4225], SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, ITGAE (integrin subunit alpha E) [NCBI Gene 3682] {aka CD103, HUMINAE}, LAMB2 (laminin subunit beta 2) [NCBI Gene 3913] {aka LAMS, NPHS5, PIERS}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Mep1b (meprin 1 beta) [NCBI Gene 17288] {aka Mep-1b}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** incontinence (MESH:D014549), colitis (MESH:D003092), diarrhoea (MESH:D003967), stenosis (MESH:D003251), mucosal damage (MESH:D052016), hypertrophy (MESH:D006984), thrombotic (MESH:D013927), Inflammatory (MESH:D007249), fistulas (MESH:D005402), infections (MESH:D007239), organ failure (MESH:D009102), IBD (MESH:D015212), smooth muscle (MESH:D018235), submucosal (MESH:C563509), carcinogenesis (MESH:D063646), IECs (MESH:C567703), motility disturbances (MESH:D015154), UC (MESH:D003093), Fibrosis (MESH:D005355), Tissue injury (MESH:D017695), CD (MESH:D003424), EMC (MESH:C563195), cancer (MESH:D009369), Intestinal injury (MESH:D007410)
- **Chemicals:** salicylates (MESH:D012459), proline (MESH:D011392), HA (MESH:D006820), DSS (-), TNBS (MESH:D014302), tocilizumab (MESH:C502936), vedolizumab (MESH:C543529)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], gut metagenome (species) [taxon 749906]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996029/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12996029/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12996029/full.md

---
Source: https://tomesphere.com/paper/PMC12996029